Study shows potential for digital microscopy for real-time accurate evaluation to aid acquisition of high quality tissue
Strategies to procure high-quality core-needle biopsy (CNB) specimens are critical for making basic tissue diagnoses and for ancillary testing. A study at MD Anderson shows the potential of a diagnostic tool called fluorescence confocal digital microscopy (FCM) for rapid and accurate diagnosis.
Results from the study, published in the March 5 issue of JAMA Network Open, demonstrated the utility of next-generation digital microscopy...
Phase I clinical trial shows WNT974 in combination with spartalizumab well tolerated for advanced solid tumor patients
An MD Anderson Phase I clinical trial demonstrated that a combination therapy using WNT974, a drug that targets the WNT pathway in cancer,...
Combination therapy key in two studies of blood cancers likely to relapse
Results from two MD Anderson studies demonstrated the significance of combination therapy in follicular lymphoma and chronic lymphoblastic...
Triple combination therapy with nivolumab is feasible for AML, MDS patients
The addition of nivolumab to induction chemotherapy with idarubicin and cytarabine is feasible in patients with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS), according to findings from a study at The University of Texas MD Anderson Cancer Center.
A study that enrolled 44 patients between August 2015 and June 2018 reported on its findings this month online at The Lancet Haematology. The...
Study defines genetic pathway for hard-to-treat form of lymphoma
A study at The University of Texas MD Anderson Cancer Center has shed information on a novel oncogenic pathway and points to the use of BET...
New approach enhances PD-L1 detection to aid in immunotherapy selection
Just as a driver’s night vision improves by simply cleaning the headlights, scientists at The University of Texas MD Anderson Cancer Center...
Novel oncogene hnRNPK identified for B-cell lymphomas
Researchers at MD Anderson Cancer Center have defined a new oncogene for B-cell lymphomas. The cancer-causing gene, known as heterogeneous...
Combination chemotherapy before blood stem cell transplant improves progression-free survival
A randomized Phase III clinical trial combining two common chemotherapy agents as a pre-stem cell transplant treatment at The University of...
Funding that makes a difference for cancer patients
Whether it is new clinical trials for pediatric cancers or programs designed to increase access to smoking cessation programs for low-income...
Clinical trials lead to FDA approval of two drugs for acute myeloid leukemia
Researchers in MD Anderson’s Leukemia department played central roles in the studies of two drugs, glasdegib and venetoclax, approved in November...